|Articles|November 1, 2002

November 2002
Volume 8
Issue 11

State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

Author(s)Jane Nelson Bolin, PhD, JD, RN, Robert J. Buchanan, PhD, Scott R. Smith, PhD

Download PDF: State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

Articles in this issue

over 23 years ago

Article

Pill Splitting

over 23 years ago

Article

Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices

over 23 years ago

Article

Use of a Disease Severity Index for Evaluation of Healthcare Costs and Management of Comorbidities of Patients With Diabetes Mellitus

over 23 years ago

Article

Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors

over 23 years ago

Article

Antibiotic Resistance: The Iowa Experience

over 23 years ago

Article

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part I: Policies, Experience, and a Framework of Preconditions

over 23 years ago

Article

Therapeutic Options for the Management of Type 2 Diabetes Mellitus

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

Articles in this issue

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Trending on AJMC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO

ACA Enrollment Erosion Deepens After Open Enrollment Ends

Efgartigimod Effective in Broad Subsets of Patients With gMG

Alopecia Areata Takes a Hidden Toll on Work, Relationships, and Self-Care